Dr. Reddy's Laboratories (NYSE: RDY), announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination ...
Zembrace SymTouch is a fast-acting acute migraine treatment option that offers a simple, two-step injection process. Zembrace SymTouch contains sumatriptan 3 mg which has been shown to provide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results